Yale researchers weigh in on zuranolone, a newly FDA-approved medication for postpartum depression poised to make a significant impact in addressing this often overlooked complication of pregnancy.
Yale researchers published a study last month revealing that over 90 percent of unaccounted pregnancy losses can be explained by placental examination.
The Yale School of Medicine’s new Center for Infection & Immunity, which launched on Aug. 18, is researching post-acute infection syndromes while encouraging diversity, elevating scientists and incorporating patients as research partners.